Savara (SVRA) Stock: Buy, Sell, or Hold?
$4.99
+0.07 (+1.42%)
▲
5d:
+7.08%
30d:
+4.39%
90d:
-5.31%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (51%)
Quality Score
55/100
Position
EXTENDED
30-Day Fair Range
$4.56 – $4.94
Position: EXTENDED
Forward P/E & Valuation
-15.4x
Next 12M consensus est.
Wall Street Target
$11.06
+121.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.33 / $5.21
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SVRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When SVRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SVRA is currently trading at $4.99, which is considered extended relative to its 30-day fair value range of $4.56 to $4.94.
Technical Outlook: Technically, SVRA is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $5.21.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.06 (+121.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SVRA is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $5.21.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.06 (+121.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.56 -
$4.94
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Trading Range & Key Levels
30-Day Trading Range
$4.56 -
$4.94
Current vs Trading Range
EXTENDED
Support Level
$4.33
Resistance Level
$5.21
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 121.6% below Wall St target ($11.06)
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-15.38
Wall Street Target
$11.06
(+121.6%)
Share SVRA Analysis
Share this live SVRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SVRA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment towards $SVRA, anticipating potential acquisition interest ahead of FDA decision for Molbreevi on November 22, 2026.
Key Retail Themes:
Acquisition speculation
FDA decision for Molbreevi
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 5:08 AM ET
Data refreshes hourly during market hours. Next update: 6:08 AM
Data refreshes hourly during market hours. Next update: 6:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SVRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SVRA Research Pages